The leukotriene E4 puzzle: Finding the missing pieces and revealing the pathobiologic implications

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 3, 2009, Pages 406-414

  Austen, K Frank ^a   Maekawa, Akiko ^a   Kanaoka, Yoshihide ^a   Boyce, Joshua A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

bronchial asthma; G protein coupled receptor; inflammation; knockout mouse; Leukotriene E4

Indexed keywords

ACETYLSALICYLIC ACID; GLUTATHIONE; LEUKOTRIENE C4; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOLEUKOTRIENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PURINERGIC P2Y12 RECEPTOR; VERLUKAST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PURINERGIC P2 RECEPTOR;

ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; EDEMA; EOSINOPHILIA; FATTY ACID METABOLISM; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; ANIMAL; DRUG ANTAGONISM; GUINEA PIG; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; SKIN;

ANIMALS; ASTHMA; GUINEA PIGS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MICE; RECEPTORS, LEUKOTRIENE; RECEPTORS, PURINERGIC P2; SKIN;

EID: 69349105178     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.05.046     Document Type: Review

References (43)

1. Brocklehurst W.E. The release of histamine and formation of a slow reacting substance (SRS-A) during anaphylactic shock. J Physiol 151 (1960) 416-435
2. Orange R.P., Murphy R.C., Karnovsky M.L., and Austen K.F. The physicochemical characteristics and purification of slow reacting substance of anaphylaxis. J Immunol 110 (1973) 760-770
3. Murphy R.C., Hammarstrom S., Samuelsson B., and Leukotriene C. a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A 76 (1979) 4275-4279
4. Marfat A., and Corey E.J. Synthesis and structure elucidation of leukotrienes. In: Pike J.E., and Morton Jr. D.R. (Eds). Advances in prostaglandin, thromboxane, and leukotriene research (1985), Raven, New York 155-228
5. Morris H.R., Taylor G.W., Piper P.J., Samhoun M.N., and Tippins J.R. Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukemia (RBL-1) cells. Prostaglandins 19 (1980) 185-201
6. Lewis R.A., Drazen J.M., Austen K.F., Clark D.A., and Corey E.J. Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun 96 (1980) 271-277
7. Yoshimoto T., Soberman R.J., Spur B., and Austen K.F. Properties of highly purified leukotriene C4 synthase of guinea pig lung. J Clin Invest 81 (1988) 866-871
8. Parker C.W., Falkenheim S.F., and Huber M.M. Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. Prostaglandins 20 (1980) 863-886
9. Lynch K.R., O'Neil G.P., Liu Q., Im D.-S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-793
10. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.-S., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30531-30536
11. Drazen J.M., Austen K.F., Lewis R.A., Clark D.A., Goto G., Marfat A., et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A 77 (1980) 4354-4358
12. Drazen J.M., Lewis R.A., Austen K.F., and Corey E.J. Pulmonary Pharmacology of the SRS-A Leukotrienes. In: Berti F., Folco G., and Velo G.P. (Eds). Leukotrienes and prostacyclin (1983), Plenum Publishing Corporation, New York
13. Drazen J.M., Venugopalan C.S., Austen K.F., Brion F., and Corey E.J. Effects of leukotriene E on pulmonary mechanics in the guinea pig. Am Rev Respir Dis 125 (1982) 290-294
14. Lee T.H., Austen K.F., Corey E.J., and Drazen J.M. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci U S A 81 (1984) 4922-4925
15. Krilis S., Lewis R.A., Corey E.J., and Austen K.F. Bioconversion of C-6 sulfidopeptide leukotrienes by the responding guinea pig ileum determines the time course of its contraction. J Clin Invest 71 (1983) 909-915
16. Lee C.W., Lewis R.A., Corey E.J., Barton A., Oh H., Tauber A.I., et al. Oxidative inactivation of leukotriene C4 by stimulated human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 79 (1982) 4166-4170
17. Lee C.W., Lewis R.A., Tauber A.I., Mehrotra M., Corey E.J., and Austen K.F. The myeloperoxidase-dependent metabolism of leukotrienes C4, D4 and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem 258 (1983) 15004-15010
18. Sala A., Voelkel N., Maclouf J., and Murphy R.C. Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem 265 (1990) 21771-21778
19. Jedlitschky G., Huber M., Volk A., Müller M., Leier I., Müller J., et al. Peroxisomal Degradation of leukotrienes by β-oxidation from the ω-end. J Biol Chem 266 (1991) 24763-24772
20. Murphy R.C., and Gijon M.A. Review article: biosynthesis and metabolism of leukotrienes. Biochem J 405 (2007) 379-395
21. Weiss J.W., Drazen J.M., Coles N., McFadden Jr. E.R., Weller P.F., Corey E.J., et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216 (1982) 196-198
22. Weiss J.W., Drazen J.M., McFadden Jr. E.R., Weller P.F., Corey E.J., Lewis R.A., et al. Airway constriction in normal humans produced by inhalation of leukotriene D: potency, time course, and effect of aspirin therapy. JAMA 249 (1983) 2814-2817
23. Davidson A.B., Lee T.H., Scanlon P.D., Solway J., McFadden Jr. E.R., Ingram Jr. R.H., et al. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic individuals. Am Rev Respir Dis 135 (1987) 333-337
24. Griffin M., Weiss J.W., Leitch A.G., McFadden Jr. E.R., Corey E.J., Austen K.F., et al. Effects of leukotriene D on the airways in asthma. N Engl J Med 308 (1983) 436-439
25. Christie P.E., Schmitz-Schumann M., Spur B.W., and Lee T.H. Airway responsiveness to leukotriene C4, leukotriene E4, and histamine in aspirin-sensitive asthmatic subjects. Eur Respir J 6 (1993) 1468-1473
26. Soter N.A., Lewis R.A., Corey E.J., and Austen K.F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. J Invest Dermatol 80 (1983) 115-119
27. Lam B.K., Penrose J.F., Freeman G.J., and Austen K.F. Expression cloning of a cDNA for human leukotriene C4 synthase, a novel integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci U S A 91 (1994) 7663-7667
28. Lam B.K., Penrose J.F., Rokach J., Xu K., Baldasaro M.H., and Austen K.F. Molecular cloning, expression, and characterization of mouse leukotriene C4 synthase. Eur J Biochem 238 (1996) 606-612
29. Kanaoka Y., Maekawa A., Penrose J.F., Austen K.F., and Lam B.K. Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J Biol Chem 276 (2001) 22608-22613
30. Maekawa A., Austen K.F., and Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 277 (2002) 20820-20824
31. Beller T.C., Maekawa A., Friend D.S., Austen K.F., and Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 44 (2004) 46129-46134
32. Maekawa A., Kanaoka Y., Xing W., and Austen K.F. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci U S A 105 (2008) 16695-16700
33. Mitra P., Oskeritzian C.A., Payne S.G., Beaven M.A., Milstien S., and Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103 (2006) 16394-16399
34. Mamedova L., Capra V., Accomazzo M.R., Gao Z.G., Ferrario S., Fumagalli M., et al. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol 71 (2005) 115-125
35. Mellor E.A., Maekawa A., Austen K.F., and Boyce J.A. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A 98 (2001) 7964-7969
36. Mellor E.A., Frank N., Soler D., Jora J.M., Hodge M.R., Austen K.F., et al. Expression of the type 2 cysteinyl leukotriene receptor by human mast cells; demonstration of function distinct from that of CysLTR1. Proc Natl Acad Sci U S A 100 (2003) 11589-11593
37. Jiang Y., Kanaoka Y., Feng C., Nocka K., Rau S., and Boyce J.A. Interleukin 4-dependent mast cell proliferation requires intracrine/autocrine cysteinyl leukotriene-dependent signaling. J Immunol 177 (2006) 2755-2759
38. Jiang Y., Feng C., Backskai B., and Boyce J.A. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene-dependent mitogenic responses of mast cells. Blood 100 (2007) 3263-3270
39. Paruchuri S., Jiang Y., Feng C., Francis S.A., Plutzky J., and Boyce J.A. Leukotriene E4 activates peroxisome proliferator activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J Biol Chem 283 (2008) 16477-16487
40. Feng C.L., Mery A.G., Beller E.M., Favot C.L., and Boyce J.A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 173 (2004) 7539-7547
41. Nonaka Y., Hiramoto T., and Fujita N. Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun 337 (2005) 281-288
42. Gauvreau G.M., Parameswaran K.N., Watson R.M., and O'Byrne P.M. Inhaled leukotriene E4, but not leukotriene D4, increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 164 (2001) 1495-1500
43. Naik S., Billington C.K., Pascual R.M., Deshpande D.A., Stefano F.P., Kohout T.A., et al. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J Biol Chem 280 (2005) 8722-8732